To find new potential
tyrosinase inhibitors, a diverse range of
2-arylchromone-4-thione derivatives (
2a
–
2p
) were designed and synthesized by employing a multistep
strategy, and the newly synthesized compounds, for the first time,
were screened in vitro for their tyrosinase inhibitory activity. In
this context, the newly synthesized compounds (
2a
–
2p
) were characterized using a combination of several spectroscopic
techniques including Fourier transform infrared, UV–vis,
1
H NMR, and
13
C NMR spectroscopies and electron
ionization–mass spectrometry. All the target compounds were
potent against tyrosinase as compared to the standard inhibitor kojic
acid (half-maximal inhibitory concentration (IC
50
) = 12.6
± 0.6 μM). The compounds (
2a
–
2p
) produced IC
50
values in the range from 1.12
± 0.04 to 5.68 ± 0.13 μM. Among the synthesized 4-thioflavones
and 4-thioflavonols, the compound
2n
exhibited excellent
tyrosinase inhibitory activity with the lowest IC
50
of
1.12 ± 0.04 μM that could be recommended as potential lead
candidates to cure tyrosinase-mediated hyperpigmentation in the future.
A kinetic study of compound
2n
revealed that compound
2n
inhibited tyrosinase in a competitive mode. Furthermore,
the nontoxic performance of the most beneficial compounds ranging
from 1 to 25 g/mL was determined using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide test method for A375 human melanoma cells for the highly efficient
target compounds (
2m
,
2n
,
2o
, and
2p
). Moreover, a molecular modeling study was
performed against tyrosinase enzyme (2Y9X) to check the binding interactions
of the synthesized compounds (
2a
–
2p
) against the target protein. Furthermore, quantitative structure-activity
relationship studies were conducted based on an antityrosinase assay.
The value of the correlation coefficient (
R
2
) 0.9997 shows that there was a good correlation between (
2a
–
2p
) structures and selected properties. The
geometry optimization of all complexes was performed by using Gaussian
09. Additionally, a drug-likeness research was used to establish the
potent analogues’ positive action as a new antityrosinase agent
(
2n
,
2o
, and
2p
).